Literature DB >> 36138050

Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life.

Migdał Anna1, Migdał Łukasz2, Okólski Adam3, Anna Chełmońska-Soyta4,5.   

Abstract

The aim of the study was to investigate the mechanisms leading to immunization through the use of a multicomponent bacterial immunomodulator and to find out the relationship between the TLR 4 receptor with selected parameters of innate immunity and to acquire immunity. The study was conducted on 18 Polish Pony Horses foals divided into two study groups: control (n = 9) and experimental (n = 9). Foals from the experimental group received intramuscular duplicate injection of 5 ml of multi-component bacterial immunomodular at 35 and 40 days of age. RNA isolated from venous blood was used to evaluate the expression of TLR4 genes using RT-PCR. Concentration of Il-6, IL-10, IgM and IgG2 was determined by the ELISA method in blood plasma. Immunostimulation had a significant impact on the level of genes expression for TLR4 expression and IL-6 concentration. No effect of stimulation on IgM and IgG2 concentrations was found. The expression of TLR4 genes as well as the levels of interleukins could be modulated by stimulation with a pharmacological agent multi-component bacterial immunomodulator. The experiment demonstrated a strong positive correlation between TLR4 gene expression and IL-6 concentration and between TLR4 gene expression and IgM concentration.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36138050     DOI: 10.1038/s41598-022-17532-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  27 in total

Review 1.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Onset of immunoglobulin production in foals.

Authors:  D L Holznagel; S Hussey; J E Mihalyi; W D Wilson; D P Lunn
Journal:  Equine Vet J       Date:  2003-09       Impact factor: 2.888

Review 3.  Immunostimulating agents: what next? A review of their present and potential medical applications.

Authors:  G H Werner; P Jollès
Journal:  Eur J Biochem       Date:  1996-11-15

4.  Absorption of bovine colostral immunoglobulins G and M in newborn foals.

Authors:  J P Lavoie; M S Spensley; B P Smith; J Mihalyi
Journal:  Am J Vet Res       Date:  1989-09       Impact factor: 1.156

Review 5.  The development of equine immunity: Current knowledge on immunology in the young horse.

Authors:  G A Perkins; B Wagner
Journal:  Equine Vet J       Date:  2015-01-06       Impact factor: 2.888

6.  Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses.

Authors:  A S Sheoran; J F Timoney; M A Holmes; S S Karzenski; M V Crisman
Journal:  Am J Vet Res       Date:  2000-09       Impact factor: 1.156

7.  Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.

Authors:  W D Wilson; J E Mihalyi; S Hussey; D P Lunn
Journal:  Equine Vet J       Date:  2001-11       Impact factor: 2.888

8.  Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.

Authors:  K M Nelson; B R Schram; M W McGregor; A S Sheoran; C W Olsen; D P Lunn
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

9.  Causes of and farm management factors associated with disease and death in foals.

Authors:  N D Cohen
Journal:  J Am Vet Med Assoc       Date:  1994-05-15       Impact factor: 1.936

10.  Effects of Separate and Concomitant TLR-2 and TLR-4 Activation in Peripheral Blood Mononuclear Cells of Newborn and Adult Horses.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.